Skip to main content

and
  1. No Access

    Chapter

    Cardiac Magnetic Resonance Imaging

    Heart disease is the leading cause of deaths in the United States. Every year approximately 735,000 Americans suffer a myocardial infarction (MI). Of these, 525,000 are a first MI, and 210,000 occur in people ...

    Róisín Morgan, Raymond Y. Kwong in Comprehensive Cardiovascular Medicine in t… (2019)

  2. No Access

    Chapter

    Assessment of Cardiomyopathies and Cardiac Transplantation

    Combining the diagnostic capabilities of CMR in the assessment of cardiac structures, myocardial perfusion, and various tissue characterizing pulse sequence methods provides a novel interrogation of myocardial...

    Róisín B. Morgan, Raymond Y. Kwong in Cardiovascular Magnetic Resonance Imaging (2019)

  3. No Access

    Chapter

    Valvular Heart Disease Assessment by CMR

    Cardiovascular magnetic resonance (CMR) has exceptional capability of performing comprehensive evaluation of simple and complex valvular heart disease. CMR has emerged as an alternative imaging modality withou...

    Patrycja Z. Galazka, Raymond Y. Kwong in Cardiovascular Magnetic Resonance Imaging (2019)

  4. No Access

    Chapter

    Contrast Agents in Cardiovascular Magnetic Resonance Imaging

    Magnetic resonance imaging (MRI) is a powerful noninvasive cardiovascular imaging modality providing excellent soft tissue contrast. Tissue contrast can be further enhanced by the use of contrast agents, enhan...

    David J. Murphy, Raymond Y. Kwong in Cardiovascular Magnetic Resonance Imaging (2019)

  5. No Access

    Chapter

    Comparison of T1 Map** by Cardiac MRI to Non-cardiac MRI Methods to Evaluate Cardiac Fibrosis

    The detection of possible underlying myocardial fibrosis is a common indication for cardiac MRI. In recent years the development of late gadolinium enhancement cardiac MRI (LGE-CMR) and T1 and T2 map** techn...

    Róisín B. Morgan, Michael Jerosch-Herold in T1-Map** in Myocardial Disease (2018)